Eagle Strategies’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $345K | Buy |
3,115
+20
| +0.6% | +$2.22K | 0.05% | 175 |
|
|
2025
Q1 | $347K | Buy |
3,095
+4
| +0.1% | +$448 | 0.06% | 163 |
|
|
2024
Q4 | $286K | Buy |
+3,091
| New | +$286K | 0.05% | 177 |
|
|
2024
Q3 | – | Sell |
-3,050
| Closed | -$209K | – | 213 |
|
|
2024
Q2 | $209K | Sell |
3,050
-149
| -5% | -$10.2K | 0.04% | 204 |
|
|
2024
Q1 | $234K | Buy |
3,199
+133
| +4% | +$9.74K | 0.05% | 239 |
|
|
2023
Q4 | $248K | Buy |
3,066
+43
| +1% | +$3.48K | 0.05% | 171 |
|
|
2023
Q3 | $227K | Buy |
3,023
+58
| +2% | +$4.35K | 0.06% | 168 |
|
|
2023
Q2 | $229K | Buy |
2,965
+4
| +0.1% | +$308 | 0.06% | 172 |
|
|
2023
Q1 | $246K | Buy |
2,961
+4
| +0.1% | +$332 | 0.06% | 159 |
|
|
2022
Q4 | $254K | Buy |
+2,957
| New | +$254K | 0.08% | 150 |
|